EUVIMEDSkopri EUVIMED
Fallbericht

Drug‐Coated Balloon Treatment for LAD CTO in a Young Woman With Moyamoya Disease Guided by Intravascular Imaging

Shuangliang Ma iD, Zhongxiu Chen iD, Baotao Huang, Mian Wang iD

Catheterization and Cardiovascular Interventions · 2025

DOI: 10.1002/ccd.31273 ↗

At a glance

Fallbericht in Catheterization and Cardiovascular Interventions, 2025. Written by Shuangliang Ma and 3 co-authors. Institution: Department of Cardiology, West China Hospital of Sichuan University, Chengdu, China. Major MEDLINE topics: Angioplasty, Balloon, Coronary, Cardiac Catheters, Cardiovascular Agents, Coated Materials, Biocompatible. 21 references. Funded by: This study was funded by a grant from the National Natural Science Foundation of China (grant number 82100282)..

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Moyamoya disease (MMD) is a rare, progressive steno‐occlusive disease of the intracranial carotid arteries. Coronary artery disease associated with MMD has been described in several cases. Coronary artery bypass grafting and percutaneous coronary intervention (PCI) with stent implantation were performed mainly for MMD patients with myocardial ischemia caused by coronary stenotic lesions. However, there have been no reports of coronary revascularization with a drug‐coated balloon in MMD patients. We present the first case report of intravascular imaging guidance of PCI with a drug‐coated balloon for a young patient with left anterior descending artery chronic total occlusion and a history of MMD. The left anterior descending artery remained patent after the 7‐month follow‐up, and there was no chest pain.

Subjects

MeSH terms (MEDLINE)

Angioplasty, Balloon, CoronaryCardiac CathetersCardiovascular AgentsCoated Materials, BiocompatibleCoronary AngiographyCoronary OcclusionMoyamoya DiseaseAdultFemaleHumansChronic DiseasePredictive Value of TestsTreatment OutcomeUltrasonography, InterventionalVascular Patency

Author keywords

Moyamoya diseasecoronary artery stenosisdrug coated balloonintravascular imagingpercutaneous coronary intervention

Substances

Cardiovascular AgentsCoated Materials, Biocompatible

Authors and institutions

  • Department of Cardiology, West China Hospital of Sichuan University, Chengdu, China.

ORCID profiles: Shuangliang Ma, Zhongxiu Chen, Mian Wang

Funding

  • This study was funded by a grant from the National Natural Science Foundation of China (grant number 82100282).

Cite

APA

Ma, S., Chen, Z., Huang, B., & Wang, M. (2025). Drug‐Coated Balloon Treatment for LAD CTO in a Young Woman With Moyamoya Disease Guided by Intravascular Imaging. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.31273

Vancouver

Ma S, Chen Z, Huang B, Wang M. Drug‐Coated Balloon Treatment for LAD CTO in a Young Woman With Moyamoya Disease Guided by Intravascular Imaging. Catheterization and Cardiovascular Interventions. 2025. doi:10.1002/ccd.31273

BibTeX
@article{Ma2025,
  author = {Ma, Shuangliang and Chen, Zhongxiu and Huang, Baotao and Wang, Mian},
  title = {Drug‐Coated Balloon Treatment for LAD CTO in a Young Woman With Moyamoya Disease Guided by Intravascular Imaging},
  journal = {Catheterization and Cardiovascular Interventions},
  year = {2025},
  doi = {10.1002/ccd.31273}
}
Start for free →